{"id":4502,"date":"2023-04-26T15:57:37","date_gmt":"2023-04-26T15:57:37","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=4502"},"modified":"2023-04-26T15:57:38","modified_gmt":"2023-04-26T15:57:38","slug":"abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/","title":{"rendered":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-285.png\" alt=\"\" class=\"wp-image-4503\" width=\"132\" height=\"132\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-285.png 200w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-285-150x150.png 150w\" sizes=\"(max-width: 132px) 100vw, 132px\" \/><\/figure>\n\n\n\n<p>Vancouver, British Columbia \u2013 <a href=\"https:\/\/abderatx.com\/\">Abdera Therapeutics Inc<\/a>., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million. The round was led by <a href=\"https:\/\/vikingglobal.com\/\">Viking Global Investors<\/a> and <a href=\"https:\/\/www.qimingvcusa.com\/\">Qiming Venture Partners USA<\/a>, with participation from <a href=\"https:\/\/www.rtwfunds.com\/\">RTW Investments, LP<\/a>, <a href=\"https:\/\/amplitudevc.com\/en\">Amplitude Ventures<\/a>, <a href=\"https:\/\/www.versantventures.com\/\">Versant Ventures<\/a>, <a href=\"http:\/\/www.venbio.com\/\">venBio<\/a>, <a href=\"https:\/\/northviewlifesciences.com\/\">Northview LifeSciences<\/a>, <a href=\"https:\/\/www.admarebio.com\/en\/\">adMare BioInnovations<\/a>, and <a href=\"https:\/\/abcellera.com\/\">AbCellera<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"715\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-286-1024x715.png\" alt=\"\" class=\"wp-image-4504\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-286-1024x715.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-286-300x210.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-286-768x536.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-286.png 1154w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>Founded by Lori Lyons-Williams, Abdera Therapeutics is based in Vancouver, British Columbia, Canada, and is focused on developing cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells.<\/p>\n\n\n\n<p>This new funding will support the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options. The precision oncology company will also expand its technology platform and advance its research and development efforts.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-287-1024x546.png\" alt=\"\" class=\"wp-image-4505\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-287-1024x546.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-287-300x160.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-287-768x409.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-287.png 1392w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>&#8220;We are thrilled to have the support of such esteemed investors, who share our vision for advancing precision oncology and developing next-generation targeted radiation therapies,&#8221; said <a href=\"https:\/\/www.linkedin.com\/in\/lorilyonsmba\/\">Lori Lyons-Williams<\/a>, Founder and CEO of Abdera Therapeutics. &#8220;This funding will enable us to further our research and development efforts and bring our innovative therapies to patients who desperately need them.&#8221;<\/p>\n\n\n\n<p>For more information on Abdera Therapeutics, please visit https:\/\/abderatx.com\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million. The round was led by Viking Global Investors and Qiming Venture Partners USA, with participation from RTW Investments, LP, Amplitude Ventures, Versant Ventures, venBio, Northview [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4506,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.<\/title>\n<meta name=\"description\" content=\"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.\" \/>\n<meta property=\"og:description\" content=\"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T15:57:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-26T15:57:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-288.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1496\" \/>\n\t<meta property=\"og:image:height\" content=\"732\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.\",\"datePublished\":\"2023-04-26T15:57:37+00:00\",\"dateModified\":\"2023-04-26T15:57:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\"},\"wordCount\":231,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\",\"name\":\"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-04-26T15:57:37+00:00\",\"dateModified\":\"2023-04-26T15:57:38+00:00\",\"description\":\"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.","description":"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/","og_locale":"en_US","og_type":"article","og_title":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.","og_description":"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.","og_url":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-04-26T15:57:37+00:00","article_modified_time":"2023-04-26T15:57:38+00:00","og_image":[{"width":1496,"height":732,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/image-288.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.","datePublished":"2023-04-26T15:57:37+00:00","dateModified":"2023-04-26T15:57:38+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/"},"wordCount":231,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/","url":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/","name":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development. - Founder Lodge Latest News Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development.","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-04-26T15:57:37+00:00","dateModified":"2023-04-26T15:57:38+00:00","description":"Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has Vancouver, British Columbia \u2013 Abdera Therapeutics Inc., a precision oncology company developing next-generation targeted radiation therapies, has announced the successful completion of its Series B funding round, raising $142 million.","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/abdera-therapeutics-raises-142-million-in-series-b-funding-round-for-precision-oncology-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Abdera Therapeutics Raises $142 Million in Series B Funding Round for Precision Oncology Development."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4502"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=4502"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4502\/revisions"}],"predecessor-version":[{"id":4507,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4502\/revisions\/4507"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/4506"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=4502"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=4502"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=4502"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}